FUNCTIONAL ROLE OF ETS1 AND AKT IN ANGIOGENESIS

$0P20FY2002RRNIH

Medical University Of South Carolina, Charleston SC

Investigators

Linked publications & trials

Paper 33068876 Paper 32450132 Paper 31028265 Paper 29235973 Paper 28932341 Paper 27746219 Paper 27503167 Paper 27398409 Paper 27213265 Paper 26878022 Paper 26650771 Paper 26307538 Paper 25886697 Paper 25463485 Paper 25013352 Paper 24583879 Paper 24578173 Paper 24469446 Paper 24337410 Paper 24324260 Paper 24295787 Paper 24272803 Paper 24011378 Paper 23751912 Paper 23531444 Paper 23517721 Paper 23512844 Paper 23468913 Paper 23254562 Paper 23165293 Paper 22843703 Paper 22827870 Paper 22811280 Paper 22709652 Paper 22579502 Paper 22546693 Paper 22307665 Paper 22087021 Paper 22036805 Paper 22010139 Paper 21978964 Paper 21971051 Paper 21917603 Paper 21749862 Paper 21666116 Paper 21665946 Paper 21618406 Paper 21562365 Paper 21554699 Paper 21538685 Paper 21491498 Paper 21399557 Paper 21362138 Paper 21266778 Paper 21181939 Paper 20811150 Paper 20739664 Paper 20629541 Paper 20603872 Paper 20549728 Paper 20549724 Paper 20359363 Paper 20201901 Paper 20200161 Paper 20132061 Paper 20096780 Paper 19945429 Paper 19781548 Paper 19723774 Paper 19661061 Paper 19638401 Paper 19334280 Paper 19246453 Paper 19195417 Paper 19179331 Paper 19176247 Paper 19150341 Paper 19074574 Paper 18948969 Paper 18816864 Paper 18776951 Paper 18694270 Paper 18691085 Paper 18661357 Paper 18661347 Paper 18598977 Paper 18597759 Paper 18538758 Paper 18524868 Paper 18511057 Paper 18489007 Paper 18375575 Paper 18326857 Paper 18313657 Paper 18312716 Paper 18097146 Paper 17962484 Paper 17948299 Paper 17947796 Paper 17822691

Abstract

DESCRIPTION (provided by applicant): Dr. Muise-Helmericks proposes to delineate the molecular mechanisms by which the potent vascular endothelial growth factor (VEGF) stimulates formation of new blood vessels. Her specific hypothesis, based on preliminary studies that included gene microarrays, is that the P13 kinase/Akt pathway is a general control point that mediates different angiogenic signals (e.g. FGF, VEGF), and that Ets-1 is a central downstream effector of this pathway.

View original record on NIH RePORTER →